A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk

Clinical trial NCT02044146 · COMPLETED

Trial details

NCT number: NCT02044146
Sponsor: Ottawa Heart Institute Research Corporation
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome Percutaneous Coronary Intervention

Start date: 2014-09-01
Primary completion: 2016-10-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.